You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
保誠(02378.HK)完成首宗肝癌組織碎化技術治療理賠
阿思達克 05-30 11:23
保誠(02378.HK)宣布,現已接受客戶透過合資格的醫療保障計劃,就肝癌組織碎化技術(Histotripsy)治療提出理賠申請。保誠已成功處理其首宗肝癌組織碎化技術治療的理賠個案,讓這項創新醫療技術真正惠及客戶。此外,港怡醫院亦提供醫療費用直付服務,協助客戶處理相關申請,大幅簡化流程。 保誠《2024年個人壽險理賠報告》指出,在消化系統相關癌症的理賠金額中,肝癌佔比達兩成。從2022年至2024年,與肝癌相關的索賠金額激增約37%,凸顯出對有效治療方案的迫切需求。 保誠保險首席客務營運及健康保障業務總監歐陽佩玲表示,透過接受與肝癌組織碎化技術治療相關的索償申請,讓這項嶄新的治療方案變得更觸手可及,為客戶帶來安心無憂的健康保障。 組織碎化技術是一項嶄新的無創肝癌超聲波治療,利用精準定位的聲波,在腫瘤組織中形成微小氣泡。當這些氣泡破裂時,能有效破壞癌細胞,而無需進行手術、針刺或放射治療。患者可於當日出院,並在數日內迅速恢復日常生活。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account